|
A8727
|
Antalarmin hydrochloride ≥98% (HPLC), solid
|
Antalarmin hydrochloride is a non-peptide CRF1 corticotropin-releasing factor receptor antagonist.
|
|
|
|
|
A4727
|
Antisauvagine-30 trifluoroacetate salt
|
High-affinity antagonist for Corticotropin-releasing factor (CRF) receptor type 2 (CRF(2)).
|
|
|
|
|
A4933
|
Astressin ≥90% (HPLC)
|
Highly potent CRF antagonist.
|
|
|
|
|
A5227
|
Astressin2B trifluoroacetate salt ≥98% (HPLC)
|
Astressin2B is a CRH2 corticotropin-releasing hormone receptor antagonist.Corticotropin Releasing Factor (CRF), its family members, and competitive antagonists such as astressin assume an alpha-helical conformation when interacting with their receptors.
|
|
|
|
|
C2917
|
Corticotropin Releasing Factor Antagonist ≥97% (HPLC)
|
The corticotropin releasing factor (CRF) antagonist α-helical CRF [9-41] exhibits 10-fold higher affinity for rat CRF2α receptors over human CRF2α receptors. It has been used to elucidate the role of CRF in various physiological systems. In colonic epithelium, it abolishes CRF-induced changes in ion secretion, and significantly inhibits CRF-stimulated conductance. It antagonizes the CRF-induced proinflammatory degranulation of perivascular mast cells that are activated in response to acute psychological stress and CRF secretion.
|
|
|
|
|
C2671
|
Corticotropin Releasing Factor bovine ≥90% (HPLC), Synthetic
|
CRF is a hypothalamic peptide that releases ACTH and endorphin from the anterior pituitary. It is also a neurotransmitter in the central nervous system, and is involved in autonomic and endocrine responses to stress.
|
|
|
|
|
C0961
|
Corticotropin Releasing Factor Fragment 6-33 human, rat ≥97% (HPLC)
|
CRF fragment that binds with high affinity to the CRF binding protein (CRF-BP) but has low affinity for the CRF receptor. Displaces CRF from CRF-BP.
|
|
|
|
|
C3042
|
Corticotropin Releasing Factor human, rat ≥95% (HPLC)
|
CRF is a hypothalamic peptide that releases ACTH and endorphin from the anterior pituitary. It is also a neurotransmitter in the central nervous system, and is involved in autonomic and endocrine responses to stress.
|
|
|
|
|
C3167
|
Corticotropin Releasing Factor sheep ≥95% (HPLC)
|
CRF is a hypothalamic peptide that releases ACTH and endorphin from the anterior pituitary. It is also a neurotransmitter in the central nervous system, and is involved in autonomic and endocrine responses to stress.
|
|
|
|
|
PZ0100
|
CP-154526 hydrochloride ≥98% (HPLC)
|
CP-154526 is a selective, non-peptide antagonist of corticotropin releasing factor receptors (CRF1).
|
|
|
|
|
L9167
|
LWH-63 hydrochloride ≥98% (HPLC), solid
|
Non-peptide CRF1 corticotrophin-releasing factor antagonist. Ki = 0.68 nM; blocks ethanol-induced effects as well as CRF effects in mice, suggesting a possible therapeutic target for the treatment of stress-induced alcohol drinking.
|
|
|
|
|
N3911
|
NBI 27914 ≥98% (HPLC)
|
NBI 27914 is a CRF1 corticotropin-releasing factor receptor antagonist.
|
|
|
|
|
S3941
|
Stresscopin trifluoroacetate salt human ≥90% (HPLC)
|
Neuropeptide involved in the stress-coping responses. Specific ligand for the corticotropin-releasing hormone receptor type 2 (CRHR2).
|
|
|
|
|
S5441
|
Stresscopin-related peptide amide human trifluoroacetate salt
|
A specific ligand for the corticotropin-releasing hormone receptor type 2 (CRHR2).
|
|
|
|
|
U4127
|
Urocortin human ≥85% (HPLC), powder
|
Binds to CRF receptor types 1, 2α, and 2β; stimulates cAMP accumulation from cells transfected with these receptors. Acts in vitro to release ACTH from rat anterior pituitary cells.
|
|
|
|
|
U1008
|
Urocortin III human ≥97% (HPLC)
|
Selective ligand with high affinity for CRF2 Receptors
|
|
|
|
|
U9507
|
Urocortin II mouse
|
corticotropin-releasing factor (CRF) peptide
|
|
|
|
|
U6631
|
Urocortin rat ≥97% (HPLC), powder
|
Binds to CRF receptor types 1, 2α, and 2β; stimulates cAMP accumulation from cells transfected with these receptors. Acts in vitro to release ACTH from rat anterior pituitary cells.
|
|
|
|